Taysha Gene Therapies (TSHA) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.1
-0.09
-0.08
-0.07

Details

Expected EPS
-0.077877
Actual EPS
-0.09
Surprise EPS
-0.01
Surprise Percent
+15.57%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.09 per share for Q3 2025.

0 Comments

Share your thoughts